haematology
Blood cancers

What is state-of-the-art management of relapsed/refractory mantle cell lymphoma?

Sponsored by Janssen-Cilag Pty Ltd

Professor Steven Le Gouill from the Centre Hospitalier Universitaire de Nantes, France, takes  delegates through state-of-the-art management of relapsed/refractory mantle cell lymphoma (R/R MCL) at the Janssen H3 medical education symposium in Melbourne. “MCL is one of those conditions where management has traditionally been more of an art than a science. While we have guidelines, ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic